CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-04-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −5,167 | $1.90 | $10K | 105,128 |
| 2011-05-16 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −7,500 | $5.53 | $41K | 115,171 |
| 2011-05-16 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −4,876 | $5.48 | $27K | 110,295 |
| 2011-04-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −8,596 | $5.76 | $49K | 122,671 |
| 2011-04-01 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Grant or award | +36,000 | 131,267 | ||
| 2011-04-01 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2011-01-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −2,985 | $5.65 | $17K | 95,267 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −300 | $5.68 | $2K | 112,952 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −50 | $5.69 | $284 | 112,902 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −850 | $5.69 | $5K | 112,052 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,000 | $5.70 | $6K | 111,052 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −3,205 | $5.70 | $18K | 107,847 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −700 | $5.71 | $4K | 107,147 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −3,592 | $5.71 | $21K | 103,555 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −100 | $5.72 | $572 | 103,455 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,900 | $5.72 | $11K | 101,555 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −100 | $5.73 | $573 | 101,455 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,400 | $5.73 | $8K | 100,055 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,003 | $5.74 | $6K | 99,052 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −600 | $5.75 | $3K | 98,452 |
Page 1 of 3 · 45 trades